Principal Financial Group Inc Cytokinetics Inc Transaction History
Principal Financial Group Inc
- $176 Billion
- Q2 2025
A detailed history of Principal Financial Group Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 1,184,805 shares of CYTK stock, worth $73.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,184,805
              Previous 629,911
              
        
           88.09%
        
      
          
        Holding current value
$73.8 Million
            Previous $25.3 Million
            
        
           54.63%
        
      
          
        % of portfolio
0.02%
            Previous 0.02%
          
        Shares
	  32 transactions
	
  Others Institutions Holding CYTK
# of Institutions
384Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M- 
    
      T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.1 Billion0.37% of portfolio
- 
    
      Black Rock Inc. New York, NY14.7MShares$913 Million0.02% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA12MShares$746 Million0.01% of portfolio
- 
    
      Wellington Management Group LLP Boston, MA7.83MShares$487 Million0.05% of portfolio
- 
    
      State Street Corp Boston, MA6.37MShares$397 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.86B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...